Connect with us

National

Oxford coronavirus vaccine induces strong immune response, early trial results suggest – NBC News

Early results in The Lancet on Oxford coronavirus vaccine clinical made by AstraZeneca suggest the COVID-19 vaccine is safe and induces antibodies and T cell response.

Published

on

post featured image

A coronavirus vaccine being developed by the University of Oxford and AstraZeneca is safe and shows signs of inducing an immune response, according to early clinical trial results published Monday in the medical journal The Lancet.
The trial did not look at whether the vaccine prevents coronavirus infection, however. That’s a question that will be answered in trials that are currently ongoing.
Full coverage of the coronavirus outbreak
The trial results found that it generated two “strong” imm…

Click here to view the original article.